5411 - 5420 of 8808 Results
Title
Year
-
OPENTitle: Eye Tracking in Patients with Parkinson’s Disease Treated with Nabilone–Results of a Phase II, Placebo-Controlled, Double-Blind, Parallel-Group Pilot StudyJournal Name: Brain SciencesPublisher: MDPI AGVol: 12Issue #: 5Start Page: 661End Page: 661Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3390/brainsci12050661Best OA location URL: https://www.mdpi.com/2076-3425/12/5/661/pdf?version=1652942510Citation Count: 9
-
OPENTitle: Clinicopathologic Correlations of Jaw Tremor in a Longitudinal Aging StudyJournal Name: Neurology Clinical PracticePublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 12Issue #: 5Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1212/cpj.0000000000200072Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/9647803Citation Count: 0
-
OPENTitle: “Stretched Slinky” SignJournal Name: Neurology Clinical PracticePublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 12Issue #: 5Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1212/cpj.0000000000200075Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/9647796Citation Count: 3
-
OPENTitle: Mobility endpoints in marketing authorisation of drugs: what gets the European medicines agency moving?Journal Name: Age and AgeingPublisher: Oxford University Press (OUP)Vol: 51Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1093/ageing/afab242Best OA location URL: https://academic.oup.com/ageing/article-pdf/51/1/afab242/42261496/afab242.pdfCitation Count: 10
-
OPENTitle: Peripheral tau as a biomarker for neurodegenerative diseases: is life on Earth, life on Mars?Journal Name: BrainPublisher: Oxford University Press (OUP)Vol: 145Issue #: 8Start Page: 2629End Page: 2631Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1093/brain/awac281Best OA location URL: https://academic.oup.com/brain/article-pdf/145/8/2629/45599741/awac281.pdfCitation Count: 1
-
OPENTitle: Chemosensory Dysfunction 3-Months After COVID-19, Medications and Factors Associated with Complete RecoveryJournal Name: Annals of Otology, Rhinology & LaryngologyPublisher: SAGE PublicationsVol: 132Issue #: 10Start Page: 1177End Page: 1185Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1177/00034894221138485Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/9742352Citation Count: 3
-
OPENTitle: Quantification of the purinergic P2X7 receptor with [11C]SMW139 improves through correction for brain-penetrating radiometabolitesJournal Name: Journal of Cerebral Blood Flow & MetabolismPublisher: SAGE PublicationsVol: 43Issue #: 2Start Page: 258End Page: 268Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1177/0271678x221126830Best OA location URL: https://journals.sagepub.com/doi/pdf/10.1177/0271678X221126830Citation Count: 5
-
OPENTitle: Common and rare GCH1 variants are associated with Parkinson's diseaseJournal Name: Neurobiology of AgingPublisher: Elsevier BVVol: 73Issue #:Start Page: 231.e1End Page: 231.e6Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.neurobiolaging.2018.09.008Citation Count: 29
-
OPENTitle: Loss of One Engrailed1 Allele Enhances Induced α-SynucleinopathyJournal Name: Journal of Parkinson's DiseasePublisher: SAGE PublicationsVol: 9Issue #: 2Start Page: 315End Page: 326Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.3233/jpd-191590Best OA location URL: https://content.iospress.com:443/download/journal-of-parkinsons-disease/jpd191590?id=journal-of-parkinsons-disease%2Fjpd191590Citation Count: 15
-
OPENTitle: Prevalence and Clinical Implications of a β-Amyloid–Negative, Tau-Positive Cerebrospinal Fluid Biomarker Profile in Alzheimer DiseaseJournal Name: JAMA NeurologyPublisher: American Medical Association (AMA)Vol: 80Issue #: 9Start Page: 969End Page: 969Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1001/jamaneurol.2023.2338Best OA location URL: https://jamanetwork.com/journals/jamaneurology/articlepdf/2807607/jamaneurology_erickson_2023_oi_230049_1689611082.26721.pdfCitation Count: 32